Multi-Target Photoprotection by Taxifolin Against UVB-Induced Keratinocyte Injury Through UVB Filtration, ROS Scavenging and Transcriptomic-Proteomic Reprogramming
Biomolecules · 04.03.2026 · 16 (3) · 387
DOI: 10.3390/biom16030387 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 04.03.2026. Verfasst von Fangfang Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: The School of Public Health and Medical Technology, Xiamen Medical College, Xiamen 361023, China. Hauptthemen laut MEDLINE: Quercetin, Reactive Oxygen Species, Keratinocytes, Ultraviolet Rays. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: General Project of Natural Science Foundation by the Science and Technology Bureau of Xiamen, Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
Taxifolin, a natural flavonoid, consistently exerts cytoprotective effects against various oxidative stresses. In this study, we systematically evaluated its photoprotective efficacy and underlying mechanisms against ultraviolet B (UVB)-induced injury in human immortalized keratinocytes (HaCaT). Cell viability and apoptosis were assessed by MTT, fluorescence staining, and flow cytometry, while integrative transcriptomic and proteomic analyses were employed to identify core pathways and key mediators. Taxifolin exhibited antioxidant capacity comparable to that of ascorbic acid under identical in vitro radical-scavenging assays. Moreover, it displayed a strong absorption peak at 289 nm that overlaps the UVB spectrum (280–320 nm), enabling it to act as a chemical sunscreen. In UVB-challenged HaCaT cells, taxifolin markedly reduced intracellular reactive oxygen species (ROS) and attenuated JNK/p38 MAPK activation, as evidenced by Western blot, thereby breaking the ROS-MAPK vicious cycle. Multi-omics revealed that taxifolin was associated with attenuation of UVB-imposed G1/S arrest concomitant with restored Cyclin expression, while up-regulating MYC, FOXQ1, HMOX1 and AP-1 components c-Jun/c-Fos and thereby switching on a pro-survival transcriptional program. Consequently, apoptosis was suppressed and survival was significantly improved. Collectively, taxifolin integrated chemical filtration, ROS scavenging and signaling modulation to support a multi-target photoprotective network, which provides mechanistic insight into taxifolin-mediated cytoprotection and identifies candidate molecular nodes for further validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The School of Public Health and Medical Technology, Xiamen Medical College, Xiamen 361023, China.
- Engineering Research Center of Natural Cosmeceuticals College of Fujian Province, Xiamen Medical College, Xiamen 361023, China.
ORCID-Profile: Fangfang Chen, Fei Li, Yu-Pei Chen
Förderung
- General Project of Natural Science Foundation by the Science and Technology Bureau of Xiamen
- Natural Science Foundation of Fujian Province
Zitieren
APA
Chen, F., Cai, Y., Wu, J., Fang, N., Li, F., Wu, H., & Chen, Y. P. (2026). Multi-Target Photoprotection by Taxifolin Against UVB-Induced Keratinocyte Injury Through UVB Filtration, ROS Scavenging and Transcriptomic-Proteomic Reprogramming. Biomolecules, 16(3), 387. https://doi.org/10.3390/biom16030387
Vancouver
Chen F, Cai Y, Wu J, Fang N, Li F, Wu H, et al. Multi-Target Photoprotection by Taxifolin Against UVB-Induced Keratinocyte Injury Through UVB Filtration, ROS Scavenging and Transcriptomic-Proteomic Reprogramming. Biomolecules. 2026;16(3):387. doi:10.3390/biom16030387
BibTeX
@article{Chen2026,
author = {Chen, Fangfang and Cai, Yihan and Wu, Jinxiong and Fang, Nengzhen and Li, Fei and Wu, Hongtan and Chen, Yu-Pei},
title = {Multi-Target Photoprotection by Taxifolin Against UVB-Induced Keratinocyte Injury Through UVB Filtration, ROS Scavenging and Transcriptomic-Proteomic Reprogramming},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {3},
pages = {387},
doi = {10.3390/biom16030387}
}
EUVIMED